Ftse Mib
34.900,48
0,49%
DAX
20.408,63
-0,02%
S&P 500
6.084,19
0,82%
NASDAQ
20.034,89
0,00%
Bitcoin
100.799,73
-0,39%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cingulate Inc (CING) Cingulate Inc (CING) Notizie

Cingulate Inc

CING
4,00
-0,28 (-6,54%)
Pre Mercato
Ultimo aggiornamento: 13:55:39
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/11/202413:30GLOBECingulate Reports Third Quarter 2024 Financial..
08/10/202421:15GLOBECingulate’s Shane Schaffer Joins Cast of Nationally..
12/9/202414:30GLOBECingulate Initiates Final Study for Lead ADHD Asset CTx-1301
03/9/202415:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/9/202415:15EDGAR2Form 8-K - Current report
31/8/202400:00EDGAR2Form SC 13D/A - General Statement of Acquisition of..
29/8/202412:16EDGAR2Form 8-K - Current report
28/8/202418:54EDGAR2Form 8-K - Current report
28/8/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
27/8/202422:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/8/202422:30GLOBECingulate to Participate in Benzinga All Live Access Event
23/8/202422:55EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/8/202422:45GLOBECingulate Announces Adjournment of Special Meeting
21/8/202401:00EDGAR2Form SC 13D/A - General Statement of Acquisition of..
20/8/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202412:39EDGAR2Form S-1 - General form for registration of securities under..
19/8/202412:06EDGAR2Form 8-K - Current report
19/8/202412:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/8/202413:45GLOBECingulate Issued European Patent for Lead Asset CTx-1301 for..
13/8/202414:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202414:00EDGAR2Form 8-K - Current report
13/8/202413:45GLOBECingulate Reports Second Quarter 2024 Financial Results and..
07/8/202415:05EDGAR2Form 8-K - Current report
30/7/202423:00EDGAR2Form 8-K - Current report
24/7/202423:11EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/7/202423:04EDGAR2Form DEF 14A - Other definitive proxy statements
17/7/202401:14EDGAR2Form SC 13D/A - General Statement of Acquisition of..
15/7/202423:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/7/202423:01EDGAR2Form S-3 - Registration statement under Securities Act of..
12/7/202423:11EDGAR2Form PRE 14A - Other preliminary proxy statements
12/7/202422:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/6/202415:15GLOBECingulate Announces Exercise of Warrants for $1.86 Million..
25/6/202422:30GLOBECingulate and ADHD Expert Dr. Ann Childress, MD to..
25/6/202415:20GLOBECingulate Achieves Key Manufacturing Milestone in the..
21/5/202415:00GLOBEFDA Clears Cingulate to File for Marketing Approval of..
08/5/202413:00GLOBECingulate Reports First Quarter 2024 Financial Results and..
30/4/202411:45GLOBEPeter J. Werth, Successful Pharma Entrepreneur,..
16/4/202423:00GLOBECingulate to Participate in Planet MicroCap Showcase: Vegas..
01/4/202414:00GLOBECingulate Inc. Reports Fourth Quarter and Full Year 2023..
19/3/202421:45GLOBECingulate to Participate in Benzinga All Live Access Event
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202412:45GLOBECingulate to Attend DCAT Week 2024 in New York City
26/2/202413:00EDGAR2Form 8-K - Current report
14/2/202423:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/2/202412:50EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 4,28

La tua Cronologia

NASDAQ
CING
Cingulate
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network